The company, however, did not disclose the value of the deal
Drug major Natco Pharma said its board has approved acquiring about 1 per cent stake in its Canadian subsidiary.
The company, however, did not disclose the value of the deal.
“The board of directors of the company at their meeting approved to acquire 0.96 per cent stake in Natco Pharma (Canada), after this acquisition Natco Pharma (Canada), (will) become a wholly-owned subsidiary company of Natco Pharma,” Hyderabad-based Natco Pharma said in a regulatory filing.
The company did not share any more details.